Real-world evidence from a retrospective study on suicide during depression: clinical characteristics, treatment patterns and disease burden

Table 6 Comparison of antidepressant distribution at admission and discharge

Antidepressant Class	MDS		χ2	P value	MDNS		χ2	P value
	Admission	Discharge			Admission	Discharge
SSRI (n, %)	2580 (53.57)^a	2371 (49.92)^a	28.795	< 0.001*	2269 (50.75)	2268 (50.94)	12.06	0.034*
SNRI (n, %)	958 (19.89)^a	1048 (22.06)^a			856 (19.15)^a	946 (21.25)^a
NaSSA (n, %)	669 (13.89)	615 (12.95)			671 (15.01)	641 (14.40)
NDRI (n, %)	91 (1.89)	83 (1.75)			71 (1.59)	62 (1.39)
Others (n, %)	172 (3.57)	184 (3.87)			168 (3.76)	170 (3.82)
Without AD (n, %)	346 (7.18)^a	449 (9.45)^a			436 (9.75)^a	365 (8.20)^a

Abbreviations: SSRI, Selective Serotonin Reuptake Inhibitors; SNRI, Serotonin-Norepinephrine Reuptake Inhibitor; NDRI, Norepinephrine Dopamine Reuptake Inhibitor. NaSSA, Noradrenergic and Specific Serotonergic Antidepressant

ISSN: 1471-244X